Skip to content
Search

Latest Stories

Submit Guest Post

Research says two new diabetes drugs may work better in Asian people

A NEW study has revealed that two new diabetes drugs are likely to be more effective in people with an Asian background than in people with a White background.

The study, published on Friday (12) in Diabetes Care and led by the University of Glasgow, found the diabetes drug classes GLP-1 receptor agonists and SGLT2 inhibitors may work better at lowering the risk of heart attack and stroke, and heart failure and death from heart disease, respectively.


People with an Asian background, including South Asian and East/Southeast people, experience a greater burden of type 2 diabetes compared with those with a White background.

As part of the study, researchers meta-analysed data from six trials of SGLT2is-four diabetes trials and two heart failure outcome trials. They also analysed data from six diabetes outcome trials for the GLP-1 receptor agonist class.

The study found a greater benefit of GLP-1RA therapy on heart attack and stroke risks in people with an Asian background compared with those with a White background across all types of the drugs tested.

The SGLT2i drugs had at least as good an effect on reducing risk of major cardiovascular events in people with diabetes in Asians, but potentially had a better effect on heart failure outcomes in this group compared with Whites in the heart failure trials, a statement said.

Naveed Sattar, professor of metabolic medicine at the University of Glasgow’s institute of cardiovascular and medical sciences, said: “These data show something potentially exciting for doctors treating Asians with diabetes. That Asians may benefit more from a class of drugs to lower heart attack and stroke risks in people with diabetes is exciting, since diabetes is more common in many Asian populations, and finding new ways to lower their cardiovascular risks is helpful”.

“At the same time, potentially better outcomes in Asians with heart failure with SGLT2 inhibitors is also exciting. Such findings now need confirmation and future trials should better categorise people with an Asian background into differing subgroups so that we can work out whether the findings apply to all people with an Asian background or specific subgroups.”

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

zia-yusuf-immigrants

Reform UK spokesperson for home affairs, Zia Yusuf, attends a press conference with Leader of Reform UK Nigel Farage at The Clermont London Hotel on November 2, 2026 in London, United Kingdom.

(Photo by Ben Montgomery/Getty Images)

Zia Yusuf shuts Braverman and Jenrick out of Reform's immigration policy

Highlights

  • Yusuf says former Tory defectors, including Braverman and Jenrick, will have no say on Reform's immigration policy
  • He says he alone would lead Reform's planned mass deportation programme
  • Labour says Reform does not trust two-thirds of its own MPs on borders

ZIA YUSUF has said that former Tory ministers who defected to Reform UK will have no say over the party's immigration policy, publicly sidelining Suella Braverman and Robert Jenrick on the issue that defines Reform.

Keep ReadingShow less